Skip to main content
. Author manuscript; available in PMC: 2017 Jan 13.
Published in final edited form as: Leukemia. 2016 Aug 2;31(1):58–64. doi: 10.1038/leu.2016.219

Figure 1. Schematic of UKALL 14 treatment protocol.

Figure 1

*High risk by karyotypes: t(9;22) t(4;11), low hypodiploidy near triploidy or complex, age >40 years WBC ≥ 30 x 109/L (pre B-ALL), ≥100 x 109/L (T-ALL), Molecular Minimal Residual Disease positivity (> 1 x 10-4) after induction phase 2